Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study

被引:4
|
作者
Fang, Chu-Wen [1 ]
Chen, Chun-Hao [1 ]
Muo, Chih-Hsin [2 ]
Wu, Shih-Chi [3 ,4 ]
机构
[1] Chi Mei Med Ctr, Div Urol, Dept Surg, Tainan, Taiwan
[2] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[3] China Med Univ, Sch Med, Taichung, Taiwan
[4] China Med Univ Hosp, Trauma & Emergency Ctr, 2 Yuh Der Rd, Taichung 404, Taiwan
关键词
H; pylori; Prostatic cancer; Peptic ulcer; Cohort study; INSURANCE RESEARCH DATABASE; INFECTION; INFLAMMATION; ESOPHAGEAL; LYMPHOMA; PATHOGENESIS; CARCINOMA; ALCOHOL; STROKE;
D O I
10.1186/s12894-020-00706-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Studies have shown diverse results regarding the association betweenH. pylori(HP) infection and the risk of malignancy. There is accumulating evidence relating HP infection to urological diseases. We investigated whether there was an association between HP-infected peptic ulcers and the subsequent risk of prostate cancer. Methods We collected HP-infected male patients from 1998 to 2008 from the Longitudinal Health Insurance Database (LHID). HP-infected patients were identified as those who had a diagnosis of peptic ulcers upon admission and received HP eradication therapy within 1 year after diagnosis. The date of HP infection diagnosis upon admission was defined as the index date. Patients aged < 20 years or with a cancer history were excluded. For each HP-infected patient, we selected four males without peptic ulcers or a history of HP eradication in the LHID for the comparison cohort according to propensity score matching by age, index year, and comorbidity. The risk of prostate cancer and associated risk factors was assessed by Cox proportional hazard regression. Results A total of 2620 HP infection treatment patients and 10,480 matched comparisons were selected. There were 36 patients in the HP-infected treatment cohort and 117 patients in the comparison cohort with documented prostate cancer development (1.52 and 1.21 per 1000 person-years, respectively). Compared to the comparison cohort, the HP infection cohort had a 1.26-fold increased prostate cancer risk in the Cox models after adjusting for matched-pairs (95% CI = 0.87-1.34). There were no significant differences in subsequent prostate cancer development between HP-infected treatment patients and the comparison cohort. Conclusion Our findings showed no significant association between HP-infected peptic ulcers and the subsequent risk of prostate cancer. Further studies are warranted to investigate whether this observation is attributable to an HP eradication policy.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease
    Chen, Yen-Chun
    Li, Yi-Da
    Yu, Ben-Hui
    Chen, Yi-Chun
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [22] A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease
    Yen-Chun Chen
    Yi-Da Li
    Ben-Hui Yu
    Yi-Chun Chen
    BMC Gastroenterology, 22
  • [23] Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study
    Wu, Meng-Che
    Huang, Jing-Yang
    Chen, Huang-Hsi
    Wei, James Cheng-Chung
    LUPUS, 2020, 29 (07) : 751 - 760
  • [24] THE EFFECT OF HELICOBACTER PYLORI ERADICATION ON THE DEVELOPMENT OF GASTRIC CANCER IN A LARGE POPULATION-BASED COHORT STUDY
    Nam, Su Youn
    Park, Bum Joon
    Nam, Ji Hyung
    GASTROENTEROLOGY, 2017, 152 (05) : S36 - S36
  • [25] Recurrence of Helicobacter pylori infection after eradication therapy in Brazilian patients with peptic ulcer
    Mesquita, MA
    Lorena, SLS
    Zeitune, JMR
    Montes, CG
    Guerrazzi, F
    Santos, JOM
    Carvalho, AEC
    Almeida, JRS
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (05) : 447 - 447
  • [26] Eradication of Helicobacter pylori was not a risk factor for reflux esophagitis in Japanese patients with peptic ulcer
    Oda, K
    Ootani, H
    Okamoto, K
    Tanaka, A
    Shimoda, R
    Nakahara, S
    Tsunada, S
    Sakata, H
    Iwakiri, R
    Fujimoto, K
    GUT, 2002, 51 : A67 - A67
  • [27] A comparative study on helicobacter pylori infection in peptic ulcer disease patients with or without previous eradication therapy
    Chen, Li-Wei
    Chien, Rong-Nan
    Fang, Kua-Meen
    Yen, Cho-Li
    Chang, Jia-Jang
    Lee, Tsung-Shih
    Liu, Ching-Jung
    Chang, Liang-Che
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2209 - 2211
  • [28] Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment in a Population-Based Multinational Cohort Study
    Wiklund, Anna-Klara
    Santoni, Giola
    Yan, Jane
    Radkiewicz, Cecilia
    Xie, Shaohua
    Birgisson, Helgi
    Ness-Jensen, Eivind
    von Euler-Chelpin, My
    Kauppila, Joonas H.
    Lagergren, Jesper
    GASTROENTEROLOGY, 2024, 167 (03) : 485 - 492.e3
  • [29] INCREASED RISK OF DEPRESSIVE DISORDER AFTR HELICOBACTER PYLORI ERADICATION: A POPULATION-BASED NESTED COHORT STUDY
    Tsai, Chia-Fen
    Chen, Mu-Hong
    Wang, Yen-Po
    Liu, Pei-Yi
    Hou, Ming-Chih
    Lee, Fa Yauh
    Lu, Ching-Liang
    GASTROENTEROLOGY, 2020, 158 (06) : S150 - S150
  • [30] Helicobacter pylori infection and the risk of colorectal cancer: a nationwide population-based cohort study
    Liu, I-L
    Tsai, C-H
    Hsu, C-H
    Hu, J-M
    Chen, Y-C
    Tian, Y-F
    You, S-L
    Chen, C-Y
    Hsiao, C-W
    Lin, C-Y
    Chou, Y-C
    Sun, C-A
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2019, 112 (10) : 787 - 792